Important: This guide is for general patient information only. It does not replace medical advice and should not be used to decide whether a prescription medicine is suitable for you. Tirzepatide is a prescription-only medicine. Treatment is only supplied where clinically appropriate after a suitable consultation and clinical review.
Weight management is not simply a question of willpower. Body weight is influenced by appetite regulation, hormones, metabolism, sleep, mental health, medical conditions, medicines, genetics, food environment and lifestyle. For some adults living with obesity or overweight with weight-related health risks, medically supervised treatment may be considered as part of a wider weight management plan.
Mounjaro is the brand name for tirzepatide. It is a prescription-only medicine used for type 2 diabetes and, in suitable adults, for weight loss and weight maintenance alongside a reduced-calorie diet and increased physical activity. It is not suitable for everyone, and it should not be used casually, cosmetically or without proper clinical assessment.
I-Prescribe is based at Unit 10F, Lister Hills Science Park, Bradford, BD7 1HR. We support patients in Bradford, West Yorkshire and across the UK with private online consultations and access to prescription medicines where clinically appropriate. Every weight management request should be reviewed carefully against BMI, medical history, current medicines, previous treatment history, lifestyle factors and individual risk.
What is tirzepatide?
Tirzepatide is a prescription medicine that acts on two hormone pathways involved in appetite and blood sugar regulation. These are known as GLP-1 and GIP pathways. GLP-1 stands for glucagon-like peptide-1, and GIP stands for glucose-dependent insulinotropic polypeptide.
These gut hormone pathways are involved in appetite, fullness, food intake, insulin response and digestion. For weight management, tirzepatide can help some patients feel fuller for longer, feel less hungry and reduce food cravings. This can support reduced food intake when combined with appropriate lifestyle changes.
It is important to understand that tirzepatide is not a quick fix. It is a medical treatment that must be used correctly, monitored appropriately and supported with changes to diet, activity and long-term behaviour. Patients should receive clear advice about realistic expectations, possible side effects, when to seek medical help and how to maintain progress safely.
What is Mounjaro used for?
Mounjaro contains tirzepatide. In the UK, tirzepatide is used for the management of type 2 diabetes and may also be used for weight loss and weight maintenance in adults who meet relevant clinical criteria.
For weight management, treatment is generally considered in adults with obesity, or in some adults who are overweight and have weight-related health problems. Weight-related health problems may include conditions such as high blood pressure, abnormal cholesterol levels, obstructive sleep apnoea, prediabetes, type 2 diabetes or a history of cardiovascular disease.
Eligibility is not based on weight alone. A healthcare professional must consider the full clinical picture, including BMI, medical conditions, current medicines, contraindications, safety risks and whether the patient can engage with lifestyle and follow-up advice.
Who may be suitable for weight management treatment?
Weight management treatment may be considered for some adults who meet clinical eligibility criteria and who have been assessed as suitable after consultation. This usually includes review of BMI and any weight-related health conditions.
A consultation should normally assess:
- Your height, weight and BMI
- Your waist measurement, where relevant
- Your previous weight loss attempts
- Your eating pattern, appetite and lifestyle factors
- Your medical history
- Your current prescription and non-prescription medicines
- Your allergy history
- Your history of diabetes, pancreatitis, gallbladder disease or stomach problems
- Your mental health history, including any eating disorder history
- Pregnancy, breastfeeding or plans to become pregnant
- Any symptoms that may need GP or urgent medical review
No responsible pharmacy or prescriber should guarantee treatment before review. Completing an online consultation does not mean that a medicine will be supplied. If treatment is not suitable, patients should be signposted to a more appropriate healthcare route.
Who may not be suitable?
Tirzepatide is not suitable for every patient. Some people may need GP review, specialist assessment or an alternative weight management approach.
Treatment may not be suitable, or may need extra caution, if you:
- Are pregnant, breastfeeding or planning pregnancy
- Have a history of pancreatitis
- Have significant gallbladder problems
- Have severe stomach or digestive problems
- Have a current or previous eating disorder
- Have complex diabetes treatment, especially insulin or sulfonylurea use
- Have severe kidney or liver impairment
- Have unexplained weight loss or concerning symptoms
- Are under the required age for treatment
- Are using another GLP-1 or weight management medicine
- Cannot safely use an injection pen or follow the treatment instructions
This list is not exhaustive. A clinician must assess suitability based on individual circumstances.
How does tirzepatide support weight management?
Tirzepatide supports weight management by acting on pathways involved in appetite and satiety. Many patients describe reduced hunger, feeling fuller after smaller meals and fewer food cravings. This can make it easier to reduce calorie intake when treatment is combined with appropriate nutrition and activity changes.
However, the medicine does not replace the need for lifestyle support. If eating patterns, protein intake, hydration, physical activity and long-term habits are not addressed, weight regain can occur after treatment is stopped. A structured plan is therefore an important part of safe and sustainable weight management.
Why lifestyle support still matters
Weight management medicines should sit within a broader plan. NHS and NICE guidance emphasise that tirzepatide should be used alongside reduced-calorie eating and increased physical activity where clinically appropriate.
A sensible lifestyle plan may include:
- Regular meals built around protein, fibre and whole foods
- Reducing high-calorie snacks, sugary drinks and alcohol intake
- Building gradual physical activity into the week
- Strength or resistance training to support muscle maintenance
- Improving sleep quality where possible
- Managing emotional eating and triggers
- Regular progress checks
- Planning how to maintain weight loss over time
Patients should avoid crash dieting, extreme restriction or unsafe “detox” approaches. Rapid changes in food intake can worsen nausea, reduce energy and make treatment harder to tolerate.
How is tirzepatide usually taken?
Tirzepatide is given as a once-weekly injection under the skin. It is normally injected into the abdomen, thigh or upper arm, depending on the instructions provided with the medicine. Injection sites should be rotated to reduce irritation.
Patients must read the patient information leaflet and injection instructions carefully before use. The pen should not be shared with another person, even if the needle is changed. Sharing injection devices can pass infections between people.
The starting dose is usually low. The dose may then be increased gradually if clinically appropriate and tolerated. This gradual approach is designed to help the body adjust and reduce the likelihood or severity of side effects. Dose increases should only happen according to clinical instructions and should not be rushed.
Why dose escalation should not be rushed
Some patients are tempted to increase the dose quickly because they want faster results. This is not safe. Dose escalation is designed to balance benefit and tolerability. Increasing too quickly can increase the risk of side effects such as nausea, vomiting, diarrhoea, constipation, indigestion, dehydration and abdominal pain.
If side effects are troublesome, a clinician may advise delaying a dose increase, remaining on the current dose, reviewing food intake, improving hydration or considering whether treatment remains appropriate. Patients should not alter the dose or schedule without clinical advice.
What side effects can happen?
Like all medicines, tirzepatide can cause side effects. Many side effects affect the stomach and digestive system, particularly when starting treatment or after a dose increase.
Commonly reported side effects may include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Indigestion
- Acid reflux symptoms
- Abdominal discomfort
- Reduced appetite
- Tiredness
- Injection site reactions
Some side effects can be managed with practical steps, such as eating smaller meals, avoiding very fatty foods, staying hydrated and not eating beyond fullness. However, symptoms that are severe, persistent or unusual should be reviewed by a healthcare professional.
Serious symptoms: when to seek urgent medical advice
Patients should seek urgent medical advice if they develop severe or persistent abdominal pain, especially if the pain spreads to the back or is associated with nausea or vomiting. This can be a warning sign of pancreatitis, which requires urgent assessment.
You should also seek medical help if you experience:
- Severe abdominal pain
- Persistent vomiting or inability to keep fluids down
- Signs of dehydration, such as dizziness, reduced urination or extreme thirst
- Yellowing of the skin or eyes
- Severe allergic symptoms, including swelling of the face, lips, tongue or throat
- Breathing difficulty
- Severe or persistent diarrhoea
- Symptoms of low blood sugar, especially if you have diabetes and use other glucose-lowering medicines
Call 999 for symptoms that feel immediately life-threatening, such as severe allergic reaction, collapse, severe breathing difficulty or severe chest pain.
Pancreatitis and gallbladder safety
GLP-1 and GIP/GLP-1 medicines have been linked with a small risk of pancreatitis. Pancreatitis is inflammation of the pancreas and can become serious. Patients should know the warning signs before starting treatment.
Gallbladder problems can also occur with weight loss and with some weight management medicines. Symptoms such as severe right upper abdominal pain, pain after fatty meals, fever, yellowing of the skin or eyes, or persistent nausea should be assessed.
Patients with previous pancreatitis, gallbladder disease or significant digestive symptoms should make this clear during consultation.
Pregnancy, breastfeeding and contraception
Tirzepatide should not be used during pregnancy. Patients who are pregnant, trying to become pregnant or planning pregnancy should not start treatment without medical advice.
If pregnancy occurs during treatment, the patient should contact a healthcare professional promptly. Patients who are breastfeeding should also seek professional advice, as treatment may not be suitable.
Some medicines can affect the absorption or effectiveness of oral medicines because they slow stomach emptying. Patients using oral contraception should ask for specific advice about whether additional contraceptive precautions are needed, especially when starting treatment or increasing dose. This should be handled as part of the clinical review.
Diabetes and blood sugar considerations
Tirzepatide is also used in type 2 diabetes. Patients with diabetes need careful assessment before starting treatment, particularly if they take insulin, sulfonylureas or other medicines that can lower blood sugar.
Weight management treatment can affect appetite, food intake and blood glucose levels. This means diabetic patients may need closer monitoring and coordination with their GP, diabetes nurse or specialist team. Symptoms such as sweating, shaking, confusion, hunger, dizziness or palpitations may suggest low blood sugar and should be addressed promptly.
What should you eat while using weight management treatment?
There is no single diet that suits every patient. The aim is usually a sustainable reduced-calorie pattern that protects nutrition and supports muscle health.
General principles may include:
- Eat smaller meals if your appetite is reduced
- Prioritise protein at meals to help maintain muscle
- Include vegetables, fruit, wholegrains and fibre where suitable
- Drink enough fluid, especially if appetite is reduced
- Reduce fried, greasy or very rich foods if they worsen nausea
- Avoid eating quickly or continuing to eat once full
- Limit alcohol, especially if it worsens reflux, nausea or appetite control
Patients should not aim for extreme restriction. Very low intake can increase tiredness, constipation, dizziness and nutritional risk. If eating becomes difficult, side effects are persistent or there are concerns about disordered eating, treatment should be reviewed.
Protein, muscle and exercise
During weight loss, the body can lose both fat and lean mass. Supporting muscle maintenance is important. Protein intake and resistance exercise can help reduce unwanted muscle loss.
Patients should consider gradually building activity according to their ability. This may include walking, cycling, swimming, resistance bands, weights or bodyweight exercise. People with long-term medical conditions, joint problems, heart symptoms or very low fitness levels should seek advice before starting strenuous exercise.
The best exercise plan is one the patient can maintain safely. Small, consistent changes usually perform better than short bursts of extreme activity.
Hydration and constipation
Reduced appetite and smaller meals can sometimes mean patients drink less fluid or eat less fibre. This can contribute to constipation, headaches and tiredness.
Practical steps may include:
- Drinking water regularly through the day
- Including fibre from vegetables, fruit, pulses or wholegrains where tolerated
- Increasing movement gradually
- Avoiding very large meals if nausea occurs
- Seeking pharmacist advice if constipation persists
Severe constipation, persistent vomiting, severe abdominal pain or inability to keep fluids down should be assessed medically.
How long does treatment take to work?
Response varies between patients. Some people notice appetite changes early, while weight change usually develops gradually over weeks and months. Treatment should be reviewed regularly to check benefit, tolerability, safety and whether the plan remains appropriate.
Patients should avoid comparing their progress with others online. Weight change can vary because of baseline weight, diet, activity, medical conditions, dose, side effects, adherence, sleep, stress and other medicines.
Responsible treatment focuses on safe progress, not the fastest possible loss.
What happens if you miss a dose?
If you miss a dose, follow the instructions in the patient information leaflet or the advice given by your clinician. Do not double up doses to make up for a missed injection unless the official instructions specifically say it is appropriate in your situation.
If you have missed several doses, have had side effects, or are unsure what to do, speak to a healthcare professional before restarting. Restarting after a break may need clinical review.
How should tirzepatide pens be stored?
Storage instructions are important. Patients should follow the patient information leaflet supplied with their medicine. Pens usually need appropriate cold-chain storage before use and should not be frozen. The medicine should not be used if it has been frozen, appears cloudy, contains particles, looks discoloured or the pen is damaged.
If travelling, patients should plan ahead and ask the pharmacy or prescriber how to store and transport the medicine safely. Do not leave pens in direct sunlight, hot cars or places where temperature cannot be controlled.
Why counterfeit and unregulated suppliers are dangerous
Patients should be cautious of websites, social media sellers or online marketplaces offering weight management injections without a proper consultation. Fake or unregulated medicines can be unsafe, ineffective, incorrectly stored, contaminated or supplied at an inappropriate dose.
Warning signs include:
- No clinical consultation
- No check of BMI or medical history
- No pharmacy registration details
- Pressure selling or discount-led messaging
- Promises of guaranteed results
- Social media sellers or private messages offering injections
- Requests for payment without proper pharmacy process
Patients should use registered UK pharmacy services and should never use a prescription medicine supplied for someone else.
Why online consultations must be detailed
Some patients find detailed consultation forms inconvenient, but the questions are there for safety. Weight management medicines can be inappropriate for patients with certain health risks or medicine interactions.
A responsible online consultation should not simply ask for weight and payment. It should assess eligibility, risks, contraindications, current medicines, relevant medical history and whether the patient needs additional review.
Where appropriate, a pharmacy may request additional information, photographs, ID verification, a video or phone consultation, GP details, consent to share relevant information with the GP, or further checks before making a decision. These safeguards protect patients and support responsible prescribing.
Should your GP be informed?
Sharing information with your GP can help keep your medical record accurate and support safer care, especially if you have diabetes, high blood pressure, mental health history, gastrointestinal conditions or take regular medicines.
Some patients prefer privacy, but there are situations where GP involvement may be clinically important. If consent to share information is requested, the pharmacy should explain why it matters and how it supports safety.
What follow-up should patients expect?
Weight management treatment should include review. Follow-up may assess:
- Weight change
- Side effects
- Hydration and nutrition
- Dose tolerance
- Adherence to treatment
- Injection technique
- Changes in medical history or medicines
- Whether treatment remains appropriate
- Whether further GP or specialist review is needed
Patients should report significant side effects promptly and should not wait until the next routine review if symptoms are severe or concerning.
What happens when treatment stops?
Stopping weight management medicine should be considered carefully. Appetite may increase after stopping, and weight regain can happen if long-term habits and support are not in place.
A maintenance plan may include:
- Regular weight monitoring
- Continuing protein and fibre-focused meals
- Maintaining physical activity
- Planning for higher-risk situations such as holidays or stress
- Ongoing support from a healthcare professional where appropriate
- Reviewing any underlying drivers of weight gain
Patients should not restart leftover medicine after a long break without clinical advice. Dose and suitability may need reassessment.
Common myths about tirzepatide and weight management
Myth 1: “The medicine does all the work.”
Treatment can support appetite control, but diet, activity, sleep, behaviour and follow-up still matter. Long-term success depends on a wider plan.
Myth 2: “Everyone is suitable.”
Not everyone is suitable. Medical history, BMI, medicines, pregnancy status, side effect risk and mental health history all matter.
Myth 3: “Faster weight loss is always better.”
Faster is not always safer or more sustainable. Severe side effects, dehydration, under-eating or nutritional problems should not be ignored.
Myth 4: “If it works for someone else, it will work for me.”
Response varies. What is suitable for one patient may not be suitable for another.
Myth 5: “Online treatment does not need proper checks.”
Online treatment still requires proper clinical safeguards. A consultation should be meaningful, and medicine should only be supplied where clinically appropriate.
How I-Prescribe approaches private weight management support
I-Prescribe provides private online consultations for weight management support where clinically appropriate. Our role is to assess suitability, support responsible medicine supply and signpost patients when online treatment is not appropriate.
Patients complete an online consultation before treatment is considered. The review may consider BMI, health history, current medicines, previous treatments, lifestyle factors and safety risks. Prescription medicine is supplied only where clinically suitable.
I-Prescribe is based in Bradford, BD7 1HR, and supports patients across the UK through online pharmacy services. Patients in Bradford, West Yorkshire and nationally can access information and consultation-led support, but treatment is never guaranteed.
When online weight management may not be enough
Online pharmacy care is not suitable for every situation. Some patients need GP review, blood tests, specialist obesity services, diabetes care, mental health support, dietetic input or urgent assessment.
You may need further assessment if you have:
- Unexplained weight loss
- Severe abdominal symptoms
- Repeated vomiting
- Symptoms of an eating disorder
- Complex diabetes treatment
- Severe mental health symptoms
- Pregnancy or breastfeeding considerations
- Severe kidney, liver, pancreatic or gallbladder disease
Responsible care includes knowing when not to supply and when to refer.
Final patient advice
Tirzepatide can be an important treatment option for some adults as part of a medically supervised weight management plan. However, it is not suitable for everyone, and it should not be obtained from unregulated sellers or used without proper clinical review.
Safe weight management requires realistic expectations, ongoing lifestyle support, side effect awareness, appropriate follow-up and honest communication with healthcare professionals.
If you are considering private weight management support, start with a proper consultation rather than choosing a medicine first. The most appropriate option depends on your BMI, medical history, current medicines, treatment goals and clinical suitability.
Learn more about weight management consultations
Frequently asked questions
Is tirzepatide the same as Mounjaro?
Mounjaro is a brand name for the medicine tirzepatide. Tirzepatide is a prescription-only medicine and should only be used where clinically appropriate.
Can I get tirzepatide online in the UK?
You may be able to start an online consultation with a registered pharmacy or healthcare provider. Medicine should only be supplied after clinical review and where suitable. Treatment is not guaranteed.
Is tirzepatide suitable for everyone who wants to lose weight?
No. Suitability depends on BMI, weight-related health risks, medical history, current medicines, pregnancy or breastfeeding status, previous treatment history and clinical assessment.
Do I still need diet and exercise?
Yes. Weight management medicine should be used alongside appropriate lifestyle changes, including reduced-calorie eating, physical activity and long-term behaviour support where suitable.
What side effects should I know about?
Common side effects can include nausea, vomiting, diarrhoea, constipation, indigestion, reflux symptoms and abdominal discomfort. Severe or persistent abdominal pain, especially if it spreads to the back or comes with vomiting, needs urgent medical advice.
Can I use tirzepatide during pregnancy?
Tirzepatide should not be used during pregnancy. If you are pregnant, planning pregnancy or breastfeeding, speak to a healthcare professional before considering any weight management medicine.
Can I use another person’s pen?
No. Injection pens must never be shared. Sharing a pen can pass infection between people, even if the needle has been changed.
What if treatment is not suitable for me?
If treatment is not suitable, you may be signposted to your GP, NHS services, specialist weight management support or another appropriate healthcare route.
Is I-Prescribe based in Bradford?
Yes. I-Prescribe is based at Unit 10F, Lister Hills Science Park, Bradford, BD7 1HR, and supports patients across the UK with online pharmacy services.
Compliance note: This article is for general patient information only. It does not advertise or guarantee access to any prescription-only medicine. Treatment decisions must be based on consultation, clinical suitability and appropriate professional review. If you have urgent or severe symptoms, seek medical advice immediately.